Wolverine Asset Management’s Verona Pharma VRNA Stock Holding History

Wolverine Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-38,419	Closed	-$4.1M	–	1883
2025 Q3	$4.1M	Buy	+38,419	New	+$4.01M	0.03%	398

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Wolverine Asset Management's VRNA Position: Q4 2025 in Review

Wolverine Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 38,419 shares — an estimated $4.1M sold.

Wolverine Asset Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $4.1M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Wolverine Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Wolverine Asset Management sold 38,419 Verona Pharma shares in Q4 2025, an estimated $4.1M.
Wolverine Asset Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Wolverine Asset Management's Verona Pharma position peaked at $4.1M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.